Skip to main content
Research project

Dr S Wilson: 'A randomised multi-centre, double-blind, placebo-controlled, parallel-group trial to explore the effects of omalizumab on airway inflammation and severe IgE-medicated asthma'

  • Research funder:
    Novartis Pharma AG
  • Status:
    Not active
Back
to top